House dust mite allergens (HDMAs) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032
-1.jpg)
House Dust Mites (HDM) are a
significant component in house dust and are responsible for most allergic
reactions to perennial allergens. Allergy to house dust mites is widespread and
can trigger allergic reactions such as asthma, eczema, and rhinitis. HDM is
arguably the allergenicity king. One of the most common causes of allergy
worldwide is atopic reactivity to their products, which affects the eyes, upper
and lower airways, skin, and systemic circulation. Dust mites' characteristics
have allowed them to colonize the indoor environment in most homes in the
world's temperate regions. Dust mites produce a wide range of immunogenic
allergens, have proteolytic activity, and are packaged with bacterial DNA,
endotoxin, chitin, and other immune-stimulating materials. HDM allergy is the
most typical cause of allergic sensitization in asthmatics. HDM extracts
derived from mite bodies, excrement, and other emanations are used in HDM
allergy's current diagnosis and immunological treatment. To ensure safety,
extracts are standardized based on their ability to elicit skin prick test
reactions in allergic volunteers rather than allergen content. Understanding
the molecular profile of HDM allergens will enable the replacement of extracts
with well-defined antigens in known and effective concentrations and the
development of new types of immunotherapy based on the allergens, their
sequences, and structures.
- In the USA, the prevalence of HDMA varies from ~ 22 MN to 25
MN cases. However, the diagnosis is as low as 40% to 50%
Thelansis’s “House dust mite allergens
(HDMAs) Market Outlook, Epidemiology, Competitive
Landscape, and Market Forecast Report – 2021 To 2032" covers disease
overview, epidemiology, drug utilization, prescription share analysis,
competitive landscape, clinical practice, regulatory landscape, patient share,
market uptake, market forecast, and key market insights under the potential House
dust mite allergens (HDMAs) treatment modalities options for eight major
markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights
of House dust mite allergens (HDMAs) across 8 MM market from the centre of
Excellence/ Public/ Private hospitals participated in the study. Insights
around current treatment landscape, epidemiology, clinical characteristics,
future treatment paradigm, and Unmet needs.
House dust mite allergens (HDMAs) Market Forecast Patient
Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs
with sourcing, Market Event, and Product Event, Country specific Forecast
Model, Market uptake and patient share uptake, Attribute Analysis, Analog
Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice
has been established based on a deep understanding of the pharma/biotech
business environment to provide an optimized support system to all levels of
the decision-making process. It enables business leaders in forward-thinking
and proactive decision-making. Thelansis supports scientific and commercial
teams in seamless CI support by creating an AI/ ML-based technology-driven
platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment